Wendell David Associates’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.69M Buy
72,984
+1,400
+2% +$122K 0.71% 34
2026
Q1
$6.1M Sell
71,584
-2,500
-3% -$223K 0.66% 37
2025
Q4
$5.85M Sell
74,084
-3,460
-4% -$271K 0.59% 40
2025
Q3
$6.2M Sell
77,544
-230
-0.3% -$19.6K 0.61% 41
2025
Q2
$7.07M Sell
77,774
-1,240
-2% -$113K 0.71% 36
2025
Q1
$7.4M Sell
79,014
-905
-1% -$81K 0.74% 36
2024
Q4
$7.26M Sell
79,919
-2,265
-3% -$216K 0.72% 35
2024
Q3
$8.53M Buy
82,184
+337
+0.4% +$34.3K 0.82% 36
2024
Q2
$7.94M Buy
81,847
+274
+0.3% +$25.3K 0.81% 35
2024
Q1
$7.35M Sell
81,573
-425
-0.5% -$36K 0.74% 38
2023
Q4
$6.54M Sell
81,998
-425
-0.5% -$32K 0.7% 38
2023
Q3
$5.86M Sell
82,423
-5,178
-6% -$387K 0.69% 37
2023
Q2
$6.75M Sell
87,601
-369
-0.4% -$28.6K 0.76% 34
2023
Q1
$6.61M Sell
87,970
-150
-0.2% -$11.2K 0.78% 35
2022
Q4
$6.94M Sell
88,120
-1,200
-1% -$90K 0.85% 32
2022
Q3
$6.28M Sell
89,320
-15
-0% -$1.18K 0.84% 34
2022
Q2
$7.16M Sell
89,335
-432
-0.5% -$33.8K 0.91% 32
2022
Q1
$6.81M Sell
89,767
-4,265
-5% -$338K 0.76% 37
2021
Q4
$8.03M Sell
94,032
-4,268
-4% -$333K 0.81% 37
2021
Q3
$7.43M Sell
98,300
-700
-0.7% -$55.6K 0.83% 35
2021
Q2
$8.05M Sell
99,000
-440
-0.4% -$36K 0.9% 34
2021
Q1
$7.84M Sell
99,440
-1,310
-1% -$103K 0.94% 32
2020
Q4
$8.62M Buy
100,750
+980
+1% +$81K 1.05% 31
2020
Q3
$7.7M Sell
99,770
-3,300
-3% -$252K 1.03% 31
2020
Q2
$7.55M Sell
103,070
-2,850
-3% -$202K 1.09% 32
2020
Q1
$7.03M Sell
105,920
-1,950
-2% -$138K 1.19% 26
2019
Q4
$7.43M Sell
107,870
-2,490
-2% -$170K 1.02% 32
2019
Q3
$8.11M Sell
110,360
-2,300
-2% -$167K 1.19% 28
2019
Q2
$8.07M Sell
112,660
-2,860
-2% -$203K 1.21% 27
2019
Q1
$7.92M Sell
115,520
-6,470
-5% -$418K 1.23% 26
2018
Q4
$7.26M Sell
121,990
-14,478
-11% -$906K 1.31% 24
2018
Q3
$9.14M Sell
136,468
-10,045
-7% -$669K 1.42% 19
2018
Q2
$9.5M Sell
146,513
-10,101
-6% -$661K 1.62% 19
2018
Q1
$11.2M Sell
156,614
-42,755
-21% -$3.08M 2.02% 13
2017
Q4
$15M Sell
199,369
-7,488
-4% -$547K 2.58% 9
2017
Q3
$15.1M Sell
206,857
-1,602
-0.8% -$115K 2.66% 8
2017
Q2
$15.5M Sell
208,459
-2,750
-1% -$204K 2.91% 7
2017
Q1
$15.5M Sell
211,209
-5,275
-2% -$369K 2.96% 7
2016
Q4
$14.2M Sell
216,484
-1,452
-0.7% -$99.6K 2.8% 6
2016
Q3
$16.2M Sell
217,936
-1,575
-0.7% -$116K 3.19% 5
2016
Q2
$16M Sell
219,511
-6,250
-3% -$445K 3.15% 5
2016
Q1
$16M Sell
225,761
-5,164
-2% -$344K 3.11% 6
2015
Q4
$15.5M Buy
230,925
+1,613
+0.7% +$107K 3.05% 6
2015
Q3
$14.4M Sell
229,312
-375
-0.2% -$24.5K 2.97% 6
2015
Q2
$14.9M Buy
229,687
+383
+0.2% +$26K 2.9% 6
2015
Q1
$15.8M Buy
229,304
+20
+0% +$1.38K 3.04% 6
2014
Q4
$15.8M Sell
229,284
-300
-0.1% -$20.3K 3.09% 5
2014
Q3
$14.9M Sell
229,584
-711
-0.3% -$46.9K 3.11% 4
2014
Q2
$15.7M Sell
230,295
-50
-0% -$3.35K 3.3% 5
2014
Q1
$15M Buy
230,345
+4,670
+2% +$294K 3.25% 4
2013
Q4
$14.7M Buy
225,675
+185
+0.1% +$11.8K 3.22% 5
2013
Q3
$13.3M Sell
225,490
-9,785
-4% -$580K 3.19% 5
2013
Q2
$13.4M Buy
+235,275
New +$14M 3.35% 5

Other funds holding CL

Wendell David Associates's CL Position: Q2 2026 in Review

Wendell David Associates increased its Colgate-Palmolive (CL) stake by 2% in Q2 2026, buying an estimated $122K and bringing the position to 72,984 shares worth $6.69M. The position accounts for 0.71% of the portfolio, ranked #34.

Wendell David Associates first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.2M in Q3 2016. 895 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Wendell David Associates held 72,984 shares of Colgate-Palmolive worth $6.69M as of Q2 2026.
  • Wendell David Associates bought 1,400 Colgate-Palmolive shares in Q2 2026, an estimated $122K.
  • Colgate-Palmolive made up 0.71% of Wendell David Associates's portfolio in Q2 2026, its #34 holding.
  • Wendell David Associates first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • Wendell David Associates's Colgate-Palmolive position peaked at $16.2M in Q3 2016.
  • 895 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Wendell David Associates's 13F filing for Q2 2026, filed 27 Jul 2026.